HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma.

Abstract
Type-C RNA tumor viruses have been implicated in the etiology of naturally occurring leukemias and lymphomas of animals. Human T-cell leukemia/lymphoma virus (HTLV) is the first human virus of this class consistently identified in association with a specific type of human leukemia/lymphoma. The isolation of HTLV was made possible by the ability to grow mature T-cells in tissue culture usually with T-cell growth factor (TCGF). We now report a cluster of adult T-cell leukemia/lymphoma among Blacks from the Caribbean in which all eight cases are positive for HTLV virus and/or antibody. These patients have disease that appears indistinguishable from Japanese adult T-cell leukemia/lymphoma which, as we have also reported, is associated with HTLV in over 90% of cases. The finding of HTLV antibodies in some of the normal population in the Caribbean and Japan, and the clustering of a specific form of T-cell leukemia/lymphoma in these virus-endemic areas, suggest that HTLV infection may be associated with the occurrence of a distinctive clinico-pathologic entity.
AuthorsW A Blattner, V S Kalyanaraman, M Robert-Guroff, T A Lister, D A Galton, P S Sarin, M H Crawford, D Catovsky, M Greaves, R C Gallo
JournalInternational journal of cancer (Int J Cancer) Vol. 30 Issue 3 Pg. 257-64 (Sep 15 1982) ISSN: 0020-7136 [Print] United States
PMID6290401 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Antigens, Viral
Topics
  • Adolescent
  • Adult
  • Animals
  • Antibodies, Viral (analysis)
  • Antigens, Viral (analysis)
  • Black People
  • Cells, Cultured
  • Female
  • Humans
  • Leukemia (immunology, pathology)
  • Lymphoma (immunology, pathology)
  • Male
  • Middle Aged
  • Radioimmunoassay
  • Retroviridae (immunology)
  • T-Lymphocytes
  • Tumor Virus Infections (immunology)
  • West Indies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: